Interojo Co (119610.KQ) Stock Price

Interojo Co Price

KOSDAQ·CLOSED
14,020.00
​
Market closed

Revenue has compounded at 17.9% per year over the past 19 years to 118.44 B KRW. Earnings per share have grown at 9.3% per year over the last 19 years. Interojo Co's net margin stands at 10.9%, down from 16.3% several years earlier. Interojo Co currently offers a dividend yield of about 4.64%. The payout ratio is around 57% of earnings. The dividend has grown at 19.7% per year over the past 15 years. Analysts set a median price target of 42,840.00 KRW, implying 205.6% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Interojo Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co business model & stock analysis

Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services.

Frequently asked questions about Interojo Co

Analysts currently set an average price target of 42,840.00 KRW for the Interojo Co stock (median: 42,840.00 KRW), implying +205.6 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Interojo Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Interojo Co to generate revenue of 134.10 B KRW and earnings per share of 2,421.74 KRW.

Converted at the current exchange rate, the Interojo Co share trades at 9.30 EUR (14,020.00 KRW).

The Interojo Co share (119610.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (119610.KQ).

The expected revenue of Interojo Co is 134.10 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Interojo Co is 27.64 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Interojo Co is currently 5.79. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Interojo Co stock.

The price-to-sales ratio (P/S) of Interojo Co is currently 1.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Interojo Co stock.

The Eulerpool Quality Score for Interojo Co is 4/10.

The ISIN of Interojo Co is KR7119610004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Interojo Co is 119610.KQ. The ticker symbol is used to trade Interojo Co shares on the stock exchange.

Fair ValueTerminal
14,861.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website interojo.com
Country
South Korea
Currency
KRW
Initial public offering
Jul 28, 2010
ISIN
KR7119610004
Cusip
Y4132R106
Market capitalization
175.67 B KRWLarge Cap
52-Week Range
PEG
0.63
P/E ratio
P/Ee 2026
6.36
P/Ee 2027
4.80
P/Ee 2028
3.70
P/S
P/Se
1.19
EV/EBIT
9.02
P/B Ratio
1.12
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
8.24 %
Dividend
Dividend yield
4.64 %
Est. Dividend Yield
8.13 %
Payout Ratio
57.34 %
Dividend growth Ø5Y
17.88 %
Dividend payments per year
1
Dividend paid since
16 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
22.00 %
Last updated Nov 5, 2026, 3:36 AM

Interojo Co Peer Group

Interojo Co Ticker

KOSDAQ · 119610.KQ

Interojo Co FIGI

119610:KS · BBG000R2D1C5119610:KQ · BBG000R2D1V4

All fundamentals and in-depth analysis of Interojo Co

Our stock analysis for Interojo Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Interojo Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.